NASDAQ: INDVIndivior PLC Stock
$21.31-0.24 (-1.11%)
Updated Sep 27, 2023
INDV Price
$21.31
Fair Value Price
N/A
Market Cap
$2.94B
52 Week Low
$21.13
52 Week High
$26.50
P/E
N/A
P/B
25.11x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
13.8
Operating Cash Flow
N/A
Beta
0.65
Next Earnings
Nov 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how INDV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
INDV is poor value based on its book value relative to its share price (25.11x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.99x)
P/B vs Industry Valuation
INDV's short-term assets ($1.09B) exceed its short-term liabilities ($972.00M)
Short-term Liabilities Financials
INDV's short-term assets ($1.09B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more INDV due diligence checks available for Premium users.
Be the first to know about important INDV news, forecast changes, insider trades & much more!
INDV News
Valuation
INDV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
25.11x
Industry
1.99x
INDV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
INDV's financial health
Profit margin
Revenue
$276.0M
Net Income
$39.0M
Profit Margin
14.1%
Assets to liabilities
Assets
$1.7B
Liabilities
$1.6B
Debt to equity
13.8
INDV's short-term assets ($1.09B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INDV's short-term assets ($1.09B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INDV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$16.0M
Investing
$127.0M
Financing
$22.0M
INDV vs Pharmaceutical Stocks
Indivior Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.